Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Somatoform disorders--what must the general practitioner know?].

Hans-Peter Volz1

  • 1Krankenhaus für Psychiatrie und Psychotherapie, Schloss Werneck. hans-peter.volz@kh-schloss-werneck.de

MMW Fortschritte Der Medizin
|November 6, 2004
PubMed
Summary

Somatoform disorders are common but diagnosable. Empathic therapy builds physician-patient trust, while treatments like opipramol and St. John's Wort show positive results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Silexan is well-tolerated for long-term use in adults and for treatment of adolescents: a real-world data analysis.

European archives of psychiatry and clinical neuroscience·2025
Same author

Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial.

European archives of psychiatry and clinical neuroscience·2024
Same author

Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials.

European psychiatry : the journal of the Association of European Psychiatrists·2024
Same author

Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan.

International journal of psychiatry in clinical practice·2023
Same author

Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials.

European archives of psychiatry and clinical neuroscience·2023
Same author

Effect of anxiolytic drug silexan on sleep - a narrative review.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2022

Area of Science:

  • Psychiatry
  • General Practice

Background:

  • Somatoform disorders are prevalent and manageable with known diagnostic criteria.
  • Establishing a strong physician-patient relationship is crucial for effective treatment.
  • Current treatment approaches include psychotherapy, psychodynamic, and behavioral therapies.

Observation:

  • Family doctors can initiate empathic, client-centered therapy.
  • This approach fosters trust and a lasting physician-patient relationship.
  • Pharmacological interventions are being explored for somatoform disorders.

Findings:

  • Opipramol and St. John's Wort extract LI 160 show initial positive results in psychopharmacological treatment.
  • These findings suggest potential new avenues for managing somatoform disorders.
  • Combining empathic communication with pharmacological treatment may be beneficial.

Implications:

  • These findings may lead to improved treatment strategies for somatoform disorders.
  • Enhanced physician-patient communication can positively impact therapeutic outcomes.
  • Further research into psychopharmacological options like opipramol and St. John's Wort is warranted.

Related Experiment Videos